Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biomea Fusion Inc (NQ: BMEA ) 9.040 -0.330 (-3.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biomea Fusion Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) November 01, 2024 From Biomea Fusion, Inc. Via GlobeNewswire Biomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist Candidate October 30, 2024 From Biomea Fusion, Inc. Via GlobeNewswire Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights October 29, 2024 From Biomea Fusion, Inc. Via GlobeNewswire Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219 October 21, 2024 Icovamenib is an oral covalent menin inhibitor in clinical development to investigate its impact on the function of insulin-producing beta cells From Biomea Fusion, Inc. Via GlobeNewswire Biomea Fusion to Host Conference Call and Webcast on Wednesday, October 30th at 4:30 pm ET to Announce Our Lead Clinical Candidate, BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist and Preclinical Data Combining BMF-219 with a GLP-1 October 15, 2024 From Biomea Fusion, Inc. Via GlobeNewswire Arcadium Lithium, Norwegian Cruise Line, GitLab, Chewy And Other Big Stocks Moving Higher On Wednesday October 09, 2024 Via Benzinga Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024) October 07, 2024 From Biomea Fusion, Inc. Via GlobeNewswire Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts October 01, 2024 International diabetes pioneers and thought leaders from 11 countries will work with Biomea leadership to unlock the potential of menin science and beta cell biology to advance BMF-219 and Biomea’s... From Biomea Fusion, Inc. Via GlobeNewswire IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session October 01, 2024 Via Benzinga FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate September 27, 2024 FDA has lifted the clinical hold on Biomea Fusion's BMF-219 trials for type 1 and type 2 diabetes following a safety review, allowing the ongoing studies to resume. Via Benzinga Exposures Product Safety Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected September 27, 2024 Via Benzinga Topics Economy Exposures Interest Rates IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday September 27, 2024 Via Benzinga FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials September 26, 2024 From Biomea Fusion, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session September 02, 2024 Via Benzinga Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) August 01, 2024 From Biomea Fusion, Inc. Via GlobeNewswire BMEA Stock Earnings: Biomea Fusion Beats EPS for Q2 2024 July 31, 2024 BMEA stock results show that Biomea Fusion beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate Highlights July 31, 2024 From Biomea Fusion, Inc. Via GlobeNewswire ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Biomea Fusion, Inc. Investors to Inquire About Securities Class Action Investigation – BMEA July 08, 2024 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Biomea Fusion, Inc. Investors to Inquire About Securities Class Action Investigation – BMEA July 03, 2024 From The Rosen Law Firm PA Via GlobeNewswire Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 17, 2024 Via Benzinga Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END Via FinancialNewsMedia BMEA ANNOUNCEMENT: If You Have Suffered Losses in Biomea Fusion, Inc. (NASDAQ: BMEA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights June 16, 2024 From The Rosen Law Firm PA Via GlobeNewswire Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies June 17, 2024 From FN Media Group LLC Via GlobeNewswire Biomea Fusion, Inc. (BMEA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings June 14, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Rosen Law Firm Encourages Biomea Fusion, Inc. Investors With Losses in Excess of $100K to Inquire About Securities Class Action Investigation – BMEA June 13, 2024 From The Rosen Law Firm, P.A. Via Business Wire Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 13, 2024 Via Benzinga This Cleveland-Cliffs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday June 11, 2024 Via Benzinga Crude Oil Edges Lower; Asensus Surgical Shares Jump June 07, 2024 Via Benzinga Exposures Fossil Fuels Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 07, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
